• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Lansoprazole inhibits oxygen-derived free radical production from neutrophils activated by Helicobacter pylori.

作者信息

Suzuki M, Nakamura M, Mori M, Miura S, Tsuchiya M, Ishii H

机构信息

Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan.

出版信息

J Clin Gastroenterol. 1995;20 Suppl 2:S93-6. doi: 10.1097/00004836-199506002-00025.

DOI:10.1097/00004836-199506002-00025
PMID:7594353
Abstract

We studied the influence of lansoprazole on Helicobacter pylori-elicited neutrophil activation, including the oxidative burst and infiltration of gastric mucosa, and confirmed whether radiolabeled lansoprazole is actually detected in gastric neutrophils. The oxidative burst of purified human neutrophils was measured by luminol-dependent chemiluminescence (ChL). [3H]Lansoprazole uptake sites in human gastric mucosa were observed by autoradiography. The magnitude of neutrophil infiltration of gastric mucosa was assessed by tissue myeloperoxidase (MPO) content. ChL assay indicated that oxygen-derived free radical production was increased twofold by adding H. pylori water extract, which was significantly inhibited by lansoprazole (10(-4) M). Gastric biopsy samples were obtained endoscopically from patients with H. pylori-positive gastritis. Autoradiographic examination revealed that the [3H]lansoprazole binding site was present in the cytoplasmic granules of infiltrated neutrophils. Tissue MPO content was significantly decreased after treatment with lansoprazole. These data suggest that lansoprazole binds directly to neutrophils, subsequently inhibiting neutrophil accumulation and release of toxic metabolites.

摘要

相似文献

1
Lansoprazole inhibits oxygen-derived free radical production from neutrophils activated by Helicobacter pylori.
J Clin Gastroenterol. 1995;20 Suppl 2:S93-6. doi: 10.1097/00004836-199506002-00025.
2
Lansoprazole reverses Helicobacter pylori-inhibited gastric epithelial cell growth.
J Clin Gastroenterol. 1995;20 Suppl 2:S90-2. doi: 10.1097/00004836-199506002-00024.
3
Uptake site of lansoprazole, a proton pump inhibitor, in human fundic mucosa: possible relevance with fibroblast and Helicobacter pylori.
Cell Mol Biol (Noisy-le-grand). 1995 Feb;41(1):125-30.
4
Proton pump inhibitor modifies inflammatory reaction in human gastric mucosa infected by Helicobacter pylori.质子泵抑制剂可改变幽门螺杆菌感染的人胃黏膜中的炎症反应。
Aliment Pharmacol Ther. 2002 Apr;16 Suppl 2:229-34. doi: 10.1046/j.1365-2036.16.s2.19.x.
5
Enhancement of neutrophil infiltration in the corpus after failure of Helicobacter pylori eradication.幽门螺杆菌根除失败后胃体中中性粒细胞浸润增强。
J Clin Gastroenterol. 1997;25 Suppl 1:S222-8. doi: 10.1097/00004836-199700001-00035.
6
Synergic interactions of macrolides and proton-pump inhibitors against Helicobacter pylori: a comparative in-vitro study.大环内酯类药物与质子泵抑制剂对幽门螺杆菌的协同相互作用:一项体外比较研究。
J Antimicrob Chemother. 1998 Mar;41 Suppl B:29-35. doi: 10.1093/jac/41.suppl_2.29.
7
Augmented eradication rates of Helicobacter pylori by new combination therapy with lansoprazole, amoxicillin, and rebamipide.采用兰索拉唑、阿莫西林和瑞巴派特新联合疗法提高幽门螺杆菌根除率。
Dig Dis Sci. 1998 Feb;43(2):235-40. doi: 10.1023/a:1018825532059.
8
Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole.兰索拉唑治疗后反流性食管炎患者的幽门螺杆菌胃炎和上皮细胞增殖
Gut. 1997 Dec;41(6):740-7. doi: 10.1136/gut.41.6.740.
9
Omeprazole attenuates oxygen-derived free radical production from human neutrophils.
Free Radic Biol Med. 1996;21(5):727-31. doi: 10.1016/0891-5849(96)00180-3.
10
A new mechanism for anti-inflammatory actions of proton pump inhibitors--inhibitory effects on neutrophil-endothelial cell interactions.质子泵抑制剂抗炎作用的新机制——对中性粒细胞与内皮细胞相互作用的抑制作用。
Aliment Pharmacol Ther. 2000 Apr;14 Suppl 1:74-81. doi: 10.1046/j.1365-2036.2000.014s1074.x.

引用本文的文献

1
Lansoprazole protects hepatic cells against cisplatin-induced oxidative stress through the p38 MAPK/ARE/Nrf2 pathway.兰索拉唑通过 p38 MAPK/ARE/Nrf2 通路保护肝细 胞免受顺铂诱导的氧化应激。
PLoS One. 2023 Jun 29;18(6):e0287788. doi: 10.1371/journal.pone.0287788. eCollection 2023.
2
Proton pump inhibitor-induced gut dysbiosis and immunomodulation: current knowledge and potential restoration by probiotics.质子泵抑制剂诱导的肠道菌群失调和免疫调节:益生菌的现有知识和潜在恢复作用。
Pharmacol Rep. 2023 Aug;75(4):791-804. doi: 10.1007/s43440-023-00489-x. Epub 2023 May 4.
3
Impact of Gastroesophageal Reflux Disease on Mucosal Immunity and Atopic Disorders.
胃食管反流病对黏膜免疫和特应性疾病的影响。
Clin Rev Allergy Immunol. 2019 Oct;57(2):213-225. doi: 10.1007/s12016-018-8701-4.
4
Proton Pump Inhibitors in IPF: A Call for Clinical Trials.特发性肺纤维化中的质子泵抑制剂:呼吁开展临床试验。
Front Pharmacol. 2018 May 17;9:499. doi: 10.3389/fphar.2018.00499. eCollection 2018.
5
Acid suppression therapy and allergic reactions.抑酸治疗与过敏反应。
Allergo J Int. 2015 Dec;24(8):303-311. doi: 10.1007/s40629-015-0085-x.
6
Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis.质子泵抑制剂埃索美拉唑的多效性作用导致肺部炎症和纤维化受到抑制。
J Transl Med. 2015 Aug 1;13:249. doi: 10.1186/s12967-015-0614-x.
7
Effects of a proton pump inhibitor on the physiological accumulation of fluoro-2-deoxy-D-glucose (FDG) in FDG-positron emission tomography.质子泵抑制剂对氟代脱氧葡萄糖(FDG)正电子发射断层扫描中生理摄取的影响。
Surg Today. 2012 Oct;42(10):927-33. doi: 10.1007/s00595-012-0265-y. Epub 2012 Jul 24.
8
Safety aspects and rational use of a naproxen + esomeprazole combination in the treatment of rheumatoid disease.萘普生+埃索美拉唑联合用药治疗类风湿性疾病的安全性及合理应用
Drug Healthc Patient Saf. 2011;3:1-8. doi: 10.2147/DHPS.S7329. Epub 2011 Mar 3.
9
Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications.质子泵抑制剂的潜在抗炎作用:临床意义的综述与讨论
Dig Dis Sci. 2009 Nov;54(11):2312-7. doi: 10.1007/s10620-009-0951-9.
10
Lansoprazole, a Proton Pump Inhibitor, Suppresses Production of Tumor Necrosis Factor-alpha and Interleukin-1beta Induced by Lipopolysaccharide and Helicobacter Pylori Bacterial Components in Human Monocytic Cells via Inhibition of Activation of Nuclear Factor-kappaB and Extracellular Signal-Regulated Kinase.兰索拉唑,一种质子泵抑制剂,通过抑制核因子-κB 和细胞外信号调节激酶的激活,抑制脂多糖和幽门螺杆菌细菌成分诱导的人单核细胞中肿瘤坏死因子-α和白细胞介素-1β的产生。
J Clin Biochem Nutr. 2009 Jul;45(1):86-92. doi: 10.3164/jcbn.08-267. Epub 2009 Jun 30.